Filing Details
- Accession Number:
- 0001061983-18-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-18 20:10:41
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-01-18 20:10:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674232 | Gordon Caryn Mcdowell | 280 East Grand Avenue South San Francisco CA 94080 | Gc & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-16 | 77 | $6.67 | 15,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 77 | $9.00 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 77 | $6.67 | 15,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 77 | $9.00 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 652 | $6.67 | 15,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 652 | $9.00 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 653 | $6.67 | 15,653 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 653 | $9.00 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 625 | $6.37 | 15,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 625 | $9.00 | 15,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-16 | 625 | $6.37 | 15,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 625 | $9.00 | 15,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-01-16 | 625 | $0.00 | 625 | $6.37 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-01-16 | 625 | $0.00 | 625 | $6.37 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-01-16 | 652 | $0.00 | 652 | $6.67 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-01-16 | 653 | $0.00 | 653 | $6.67 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-01-16 | 77 | $0.00 | 77 | $6.67 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-01-16 | 77 | $0.00 | 77 | $6.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,250 | 2016-05-29 | 2025-05-29 | No | 4 | M | Direct |
| 10,625 | 2016-05-29 | 2025-05-29 | No | 4 | M | Direct |
| 18,691 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
| 18,038 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
| 998 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
| 921 | 2016-03-23 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
Billionaire Hedge Funds
